IGF::OT::IGF ADVANCE UNIVERSAL INFLUENZA VACCINE CANDIDATES BASED ON RBD-FERRITIN NANOPARTICLES
$193,201N01FY2018CANIH
Leidos Biomedical Research, Inc., Frederick MD
Investigators
Abstract
IGF::OT::IGF ADVANCE UNIVERSAL INFLUENZA VACCINE CANDIDATES BASED ON RBD-FERRITIN NANOPARTICLES
View original record on NIH RePORTER →